… successful cancer immunotherapy strategies … innate lymphocytes by ICI in both solid tumors
and hematological malignancies. Overall, we believe that, in our near future, immunotherapy …

… opportunities in cancer. Ideally innate lymphocyte responses would be modulated to work
in parallel with anti-tumor T cells to promote potent and long-lasting anti-tumor immunity. …

… -based immunotherapies. Notably, myeloid cells and innate lymphocytes contribute to both
… Finally, selective context-specific targeting of the innate immune system has the potential to …

… cancer immunotherapies. The generation of a spontaneous T cell response against tumor-associated
antigens depends on innate … , suggesting that failed innate immune activation may …

… The innate immune system is critical for inducing durable and protective T cell responses to
… for cancer immunotherapy. In this review, we present a framework wherein distinct innate …

… the emergence of cancer immunotherapy, a new kind of therapeutic strategy in which the
immune system is boosted, to enable it to kill tumor cells [5]. Immunotherapies may target the …

… A critical concept underlying the current view of immunotherapy is that the ultimate end-effector
and therapeutic target of cancer immunotherapy is the tumour-specific T-cell. An …

… to enhance the efficacy of both endogenous protective antitumour antibodies involved in
immunosurveillance and exogenous antitumour antibodies used in cancer immunotherapy. …

… synergistic effects in cancer immunotherapy have been evidenced when innate and adaptive
… innate and adaptive immune responses is necessary for efficient cancer immunotherapy. …

… Despite the unprecedented success of this first wave of cancer immunotherapies based
on immune checkpoint inhibitors and CAR T cells, many people fail to benefit from such …